ARTICLE | Clinical News
Axanum aspirin/esomeprazole magnesium regulatory update
June 7, 2010 7:00 AM UTC
AstraZeneca submitted an MAA in Europe for Axanum aspirin/esomeprazole to prevent cardiovascular and cerebrovascular events in patients requiring continuous low-dose aspirin treatment who are at risk ...